Bayer HealthCare is successfully integrating the recently acquired Teva Animal Health by beginning the process of introducing products to the U.S. market under the Bayer brand. This U.S. acquisition was the largest-ever for Bayer HealthCare's Animal Health Division, broadening the portfolio with complementary companion and food animal products.

The seven DVM dermatology and supplement products reintroduced to U.S. veterinarians were: ChlorhexiDerm 4% Shampoo; Free Form Liquid; Malase Flush; OtiRinse; Relief Creme Rinse; and Relief Spray. In addition, Preva Medicated Wipes were launched. Over the next 12 to 18 months, additional products from the acquisition will continue to enter the U.S. market.

In 2012, Bayer HealthCare signed an agreement to acquire the US-Animal Health business based in St. Joseph, Missouri. The acquisition reinforced the food animal franchise of Bayer HealthCare by providing a range of anti-infective solutions for livestock and introducing reproductive hormones to Bayer's product offerings. This transaction also strengthened Bayer HealthCare's companion animal franchise by expanding its portfolio with dermatological, pet wellness and nutraceutical products.